CHEALEMBIC deferasirox 360 mg film-coated tablet blister pack

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

deferasirox, Quantity: 360 mg

Verfügbar ab:

Alembic Pharmaceuticals Australia Pty Ltd

Darreichungsform:

Tablet, film coated

Zusammensetzung:

Excipient Ingredients: povidone; magnesium stearate; colloidal anhydrous silica; poloxamer; sodium starch glycollate type A; microcrystalline cellulose; crospovidone; titanium dioxide; hypromellose; indigo carmine aluminium lake; purified talc; macrogol 4000

Verabreichungsweg:

Oral

Einheiten im Paket:

30

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

The treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adults and paediatric patients 6 years and older. CHEALEMBIC is also indicated for the treatment of chronic iron overload in paediatric patients aged 2 to 5 years who are unable to take desferrioxamine therapy or in whom desferrioxamine has proven ineffective.,CHEALEMBIC is also indicated for the treatment of chronic iron overload in patients with non-transfusion- dependent thalassemia syndromes aged 10 years and older.

Produktbesonderheiten:

Visual Identification: Dark blue, oval, biconvex, film-coated tablet with beveled edges, debossed with "L" on one side and "665" on the other side. Approximately 17 mm in length and approximately 7 mm in width.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2020-11-16